Site icon Health Thoroughfare

WHO News: There Is No Evidence Healthy Kids And Adolescents Need Covid Boosters

Credit: Pixabay.com

Credit: Pixabay.com

The subject of covid boosters and their necessity has been long debated. The opinions on this subject are many, and while some people cannot wait to get more shots in order to be more protected, in their opinion, others are saying that more studies and evidence had to be conducted to say that vaccines and boosters are effective. 

“There is no evidence at present that healthy children and adolescents need booster doses of covid 19 vaccine, the World Health Organization’s chief scientist Soumya Swaminathan said on Tuesday.”

This is what the Reuters press agency revealed. 

Moderna expects covid trial data for kids between 2 to 5 years

Not too long ago, we were revealing that Moderna said that it’s expecting to report data from their vaccine trial in kids aged 2 to 5 in March.

According to the Reuters press agency the company said the following: 

“If the data is supportive and subject to regulatory consultation, Moderna may proceed with regulatory filings for children 2-5 years of age thereafter.”

It’s been also revealed that Moderna’s vaccine is based on the messenger RNA platform, and it already has authorizations in Europe, UK, Australia, and Canada for adolescents aged 12-17 years. It is also important to note the fact that the company has submitted applications for children in 6 to 11 years.

In the United States, the vaccine is authorized by Food and Drug Administration as a primary two-dose regimen and booster dose for adults 18 years and older. The company still has to get authorization from the regulator for use of its vaccine in children.

Source: Pixabay

We suggest that you check out the complete article we wrote a few days ago, in order to learn all the available details about the subject. 

Also, there’s a new early warning system that can predict the highest-risk coronavirus variants simply from their genetic code.

This will alert health authorities and vaccine developers to the potential risks months before they spread, a new study said.

Exit mobile version